Renowned Orthopedic Surgeon, Dr. Stephen Hochschuler, Joins Backstop Neural’s Advisory Board

Backstop Neural, a pioneering company specializing in advanced spinal cord stimulation solutions, is pleased to announce the appointment of Dr. Stephen Hochschuler to its esteemed Technical Advisory Board.

Dr. Stephen Hochschuler is a distinguished figure in the medical field, renowned for his groundbreaking work in orthopedic surgery. With over four decades of experience, Dr. Hochschuler has consistently pushed the boundaries of medical science, contributing significantly to the advancement of surgical techniques and patient care.

As a member of Backstop Neural’s Advisory Board, Dr. Hochschuler will bring his wealth of knowledge and expertise to the company’s mission of relieving pain and restoring movement. His extensive experience in the medical field, coupled with his visionary approach to healthcare, makes him an invaluable addition to the team.

“We are honored and thrilled to welcome Dr. Stephen Hochschuler to our Advisory Board,” said Connie Manz, CEO and Co-founder of Backstop Neural. “His dedication to improving the lives of patients aligns perfectly with our mission, and we believe his strategic insights and network will be instrumental in driving our neural interface technology forward.”

Dr. Hochschuler’s accomplishments include serving as co-founder of the renowned Texas Back Institute, one of the largest spine specialty clinics globally, and authoring numerous publications in esteemed medical journals. He is also a founding member of The American Board of Spine Surgery and The American College of Spin Surgery. His commitment to excellence and passion for innovation make him an ideal collaborator for Backstop Neural’s journey in creating revolutionary neural interfaces.

Backstop Neural is transforming delivery of electrical stimulation of the spinal cord for pain relief and motor recovery by leveraging novel materials and processes. Combining expertise from various fields enables the company to push the boundaries of what’s possible in the realm of neural interfaces.

Dr. Hochschuler’s appointment comes at a pivotal time for Backstop Neural as the company continues to make significant strides in its product development efforts. His contributions to the Technical Advisory Board will undoubtedly play a crucial role in shaping the future of spinal cord stimulation for pain and motor recovery.

 

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."